One Year Drug Treatment in First-Episode Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Schizophrenia
Interventions
DRUG

Haloperidol, Risperidone (drug)

targeted dose of 2-4 mg/day over 1 year

Trial Locations (1)

40629

Department of Psychiatry and Psychotherapy at the Heinrich-Heine-University, Düsseldorf

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

German Research Network On Schizophrenia

NETWORK

collaborator

Janssen-Cilag Ltd.

INDUSTRY

collaborator

University of Bonn

OTHER

collaborator

Humboldt-Universität zu Berlin

OTHER

collaborator

University of München

OTHER

collaborator

University of Göttingen

OTHER

collaborator

University of Cologne

OTHER

collaborator

Mainz University

OTHER

collaborator

University Hospital Tuebingen

OTHER

collaborator

Universität Duisburg-Essen

OTHER

collaborator

University of Mannheim

OTHER

collaborator

University of Jena

OTHER

collaborator

Martin-Luther-Universität Halle-Wittenberg

OTHER

collaborator

RWTH Aachen University

OTHER

collaborator

University of Wuerzburg

OTHER

lead

Heinrich-Heine University, Duesseldorf

OTHER

NCT00159081 - One Year Drug Treatment in First-Episode Schizophrenia | Biotech Hunter | Biotech Hunter